Celldex Therapeutics (CLDX) EBT Margin Growth (1y) (2011 - 2026)
Celldex Therapeutics (CLDX) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Celldex Therapeutics |
2.16 Bn |
2.16 Bn |
-1.44 Mn |
-51.68 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-51.68 Mn |
| Dec 31, 2025 |
-6.32 Mn |
| Jun 30, 2025 |
-631,860.00 |
| Mar 31, 2025 |
1.33 Mn |
| Dec 31, 2024 |
-295,951.00 |
| Sep 30, 2024 |
120,209.00 |
| Jun 30, 2024 |
994,652.00 |
| Mar 31, 2024 |
-1.80 Mn |
| Dec 31, 2023 |
59,378.00 |
| Sep 30, 2023 |
405,875.00 |
| Jun 30, 2023 |
1.07 Mn |
| Mar 31, 2023 |
1.02 Mn |
| Dec 31, 2022 |
439,024.00 |
| Sep 30, 2022 |
693,485.00 |
| Jun 30, 2022 |
-2.17 Mn |
| Mar 31, 2022 |
-1.08 Mn |
| Dec 31, 2021 |
-542,909.00 |
| Sep 30, 2021 |
-1.14 Mn |
| Jun 30, 2021 |
438,648.00 |
| Mar 31, 2021 |
-171,292.00 |
